Shelley Steele, Chief Executive Officer

Shelley Steele is the Chief Executive Officer of The Aliera Companies. Relying on her 25 years of experience in executive management, she is responsible for providing strategic leadership and oversight of the financial stability of the company and its subsidiaries. Shelley leads the development of Aliera’s innovative solutions that simplify the complexities of the healthcare experience, and she works closely with executive management, the Advisory Board, and the company’s directors to establish long-range goals, policies and plans for sustainable growth. She is a member of the Healthcare Administrators Association and The National Association for Healthcare Quality and has served on multiple boards, both private and public.

Chase Moses, President

As President of The Aliera Companies, Chase Moses uses his expertise in enterprise creation and development to enhance operational infrastructure and drive growth.  He assisted in building Aliera from the ground up, playing a vital role in generating more than $200 million in revenue within the company’s last three years. Chase has also been instrumental in building Aliera’s team of 400 agents of change who are redefining the healthcare experience for individuals, families and employers with innovative solutions that simplify the complexities of the healthcare experience and unlock the power of choice. In his role, Chase has designed and implemented the corporate restructure to provide transparency to regulatory bodies, while creating additional revenue lines through additional business-to-business relationships.

John Blenke, Board Member and Senior Consultant of Compliance & Regulatory Affairs

Mr. Blenke is an established legal professional with over 35 years’ experience with corporate governance, corporate finance, public company, securities, litigation, M&A, information security and general risk management issues, with focus on the use of consumer data within regulated industries in the United States and globally. As the former EVP and Corporate counsel of Transunion for over 15 years, his executive experiences in internal and external legal support, and global regulatory, compliance, government affairs, public policy and corporate investigations functions, enables Aliera to reliably, professionally and ethically collect non-public personal information and to establish appropriate security and use controls to meet changing regulatory and privacy concerns. Prior to serving with Transunion Mr. Blenke served as VP Law, Household International/HSBC for 14 years.

Roger Sevigny, Board Member and Former New Hampshire Insurance Commissioner

Mr. Sevigny is a former insurance commissioner for the state of New Hampshire, a position he served for 15 years in the administrations of both republican and democratic governors.  Concurrent with his state service, he was elected president of the National Association of Insurance Commissioners (NAIC) and was later honored for his distinguished service to the organization with their annual President’s Award for Leadership. He currently serves on the Consumer Advisory Committee of the Interstate Insurance Product Registry Compact. Before entering public service, he held several positions with Travelers Insurance/Citigroup and worked his way through the ranks into senior leadership, during a tenure of more than 30 years.

Ted Strickland, Board Member and Former Ohio Governor

Dr. Strickland was elected Ohio’s 68th governor in 2006 and worked with legislators on both sides of the aisle to stimulate economic progress that helped foster a thriving middle class. Prior to his service as governor, he was elected to six terms in the United States House of Representatives. After leaving public office in 2011, Strickland became a fellow at the Institute of Politics at Harvard University, served as an alternate delegate to the United Nations General Assembly and was a member of the Governor’s Council at Ohio’s Bipartisan Policy Center. Most recently, he served as president of The Center for American Progress Action Fund and as a fellow at the T.H. Chan School of Public Health at Harvard University.